PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New antibody targeting approach, tested in mice, improves distribution and safety of Alzheimer’s immunotherapies

Summary author: Walter Beckwith

2025-08-07
(Press-News.org) A newly engineered antibody transport vehicle targeting the transferrin receptor enables enhanced delivery of anti-amyloid antibodies to the brains of mouse models of Alzheimer’s disease, researchers report. According to the study, the approach preserves key immune functions, such as microglial clearance of plaques, while offering a safer and more effective delivery strategy for anti–amyloid immunotherapies. Alzheimer’s disease (AD) is marked by the buildup of amyloid-β (Aβ) protein plaques in the brain. FDA-approved anti-amyloid drugs, like aducanumab, lecanemab, and donanemab, have shown limited success in reducing Aβ plaque buildup and slightly slowing cognitive decline in AD. Still, they do not stop the disease from progressing. Their clinical benefits might be further constrained by suboptimal penetration into the brain and by common side effects, including brain swelling and small brain bleeds, collectively known as amyloid-related imaging abnormalities (ARIA). To overcome these limitations, Michelle Pizzo and colleagues engineered a novel antibody transport vehicle (ATV) that targets the transferrin receptor – a natural gateway on blood vessels that allows certain molecules to cross the BBB. The design, called ATVcisLALA, incorporates a mutation to reduce harmful interactions with immune receptors on immature red blood cells, thereby preventing cytotoxic side effects. In a mouse model of AD, Pizzo et al. show that, when fused with an anti–amyloid-β antibody (creating ATVcisLALA:Aβ), the modified therapy successfully entered brain tissue more efficiently than conventional antibodies. Notably, ATVcisLALA:Aβ distributed broadly throughout the brain parenchyma, increasing brain concentrations by five- to eightfold. The researchers’ approach also showed enhanced targeting of plaque-associated Aβ in brain tissue rather than in blood vessels, which reduced vascular inflammation and significantly lowered the incidence of ARIA-like side effects. “Taken together, the findings of Pizzo et al. provide more than preclinical proof of concept; they also establish a framework for therapeutic design,“ write Mengen Xing and Weihong Song in a related Perspective. “By precisely controlling the route of antibody entry and modulating its function, ATVcisLALA:Aβ overcomes long-standing limitations of AD immunotherapy.

END


ELSE PRESS RELEASES FROM THIS DATE:

UC Irvine scientist takes a lesson from ultrahard, wear-resistant mollusk teeth

2025-08-07
  Irvine, Calif. — Researchers at the University of California, Irvine and Japan’s Okayama and Toho universities conducted a first-of-its-kind study to understand how chitons, mollusks that feed on algae growing on intertidal rocks, develop such hard, wear-resistant and magnetic teeth, and what they learned is inspiring new ways to produce advanced materials for a variety of applications. The results were published today in Science. In its study, the team unveiled the process by which chiton-specific, iron-binding ...

ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials

2025-08-07
The ability to detect single photons (the smallest energy packets constituting electromagnetic radiation) in the infrared range has become a pressing need across numerous fields, from medical imaging and astrophysics to emerging quantum technologies. In observational astronomy, for example, the light from distant celestial objects can be extremely faint and require exceptional sensitivity in the mid-infrared. Similarly, in free-space quantum communication—where single photons need to travel across vast distances—operating in ...

New scaffold technology helps combat traumatic brain injury by restoring copper balance

2025-08-07
Traumatic brain injury (TBI) remains one of the leading causes of disability worldwide. Recent research has developed a novel electrospun scaffold loaded with copper oxide (CuO@PG), which aims to restore copper homeostasis and modulate inflammation in TBI. The study shows that CuO@PG scaffolds significantly reduce neuronal pyroptosis (a form of programmed cell death), alleviate brain swelling, and improve motor and cognitive functions in animal models. These findings provide a promising therapeutic approach to mitigate the neurodegenerative effects ...

Bone metastases cultivate immature immune cells to resist immunotherapy

2025-08-07
AUGUST 7, 2025, NEW YORK – Many major cancers, including those of the lung, breast and prostate gland, spread to the bones as they progress. These bone metastases are often debilitating, even deadly. They are also notoriously resistant to all kinds of treatment, including immunotherapy. Now a Ludwig Cancer Research study has identified in the microenvironment of bone tumors a key architect of that resistance. Researchers co-led by Taha Merghoub and Tao Shi of the Ludwig Collaborative Laboratory at Weill Cornell Medicine with colleagues at Nanjing ...

Liming can help enhance carbon capture in agricultural fields

2025-08-07
Adding crushed calcium carbonate — limestone — to agricultural fields can remove tons of carbon dioxide from the atmosphere each year while improving crop yields, a Yale-led study published in Nature Water found. Greenhouse gases in the atmosphere hit a record high in 2024 reaching over 420 parts per million. The U.N. Intergovernmental Panel on Climate Change (IPCC) has identified carbon removal as one key tool in limiting warming to 1.5 C above pre-industrial levels to help mitigate climate change. To reach that target, 15 billion tons of carbon would have to be removed from the atmosphere each year. “There ...

National study urges expanded vaccine screening in emergency departments

2025-08-07
RIVERSIDE, Calif. -- About 49% of people are unaware of one or more vaccines recommended for them. Further, 86% have not received one or more of these vaccines. These are the findings of a University of California, Riverside-led study published today in Morbidity and Mortality Weekly Reports. The study is the first national comprehensive vaccine surveillance study conducted in emergency departments, or EDs — the only health care access point for millions of underserved Americans. “Vaccination screening is one of the most fundamental public health interventions,” ...

Simple color-changing sensor quickly identifies poisonous gases

2025-08-07
Not all poisonous gases have a smell or a color. But a tiny grid of pastel- and candy-colored squares that effectively “sniffs” out hazardous chemicals in the air such as chlorosarin — a highly toxic nerve agent — could help detect them. Researchers report in ACS Sensors that the colorful patterns in their inexpensive and durable paper-based sensor array changed in the presence of poisonous gases, allowing for quick and accurate measurements within minutes.      Electronic noses, ...

Exosomes found to play a double role in tumor growth and immune response

2025-08-07
Tiny extracellular vesicles known as exosomes are emerging as key regulators of the tumor microenvironment (TME), influencing how cancer progresses, spreads, and responds to treatment. In a new review published in Med Research, researchers from Haikou Affiliated Hospital of Central South University Xiangya School of Medicine explore the dual nature of exosomes—highlighting their roles in both tumor promotion and immune modulation. “Exosomes are not just passive carriers,” said Dr. Jiachong Wang, co-corresponding author of the paper. “They actively shape tumor biology by transferring RNAs, proteins, and ...

Announcing Gordian Biotechnology as Tier 5 Sponsor of ARDD 2025

2025-08-07
The University of Copenhagen is excited to announce Gordian Biotechnology as a Tier 5 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.  Gordian Biotechnology is a therapeutics company transforming how the industry discovers and develops treatments for age-related diseases. By integrating pooled screening in naturally occurring disease models, single-cell analysis, and in vivo gene therapy, ...

Disconnection between brain regions explains why some people don’t enjoy music

2025-08-07
Ten years ago, researchers discovered a small group of people who derive no pleasure from music despite having normal hearing and the ability to enjoy other experiences or stimuli. The condition, “specific musical anhedonia,” is caused by a disconnect between the brain’s auditory and reward networks. In a paper publishing August 7 in the Cell Press journal Trends in Cognitive Sciences, the team that discovered specific musical anhedonia describes the brain mechanisms behind the condition and discusses how understanding it could reveal other differences in how people experience ...

LAST 30 PRESS RELEASES:

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

2026 Hertz Fellowship Application Now Open

The gut immune system is altered in mouse model of Alzheimer’s, providing a new target for therapeutics

ADHD drugs are being prescribed too quickly to preschoolers

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer

Extreme heat linked to spike in domestic violence calls in New Orleans, study finds

Mount Sinai-Duke University study identifies DNA variants that increase testosterone production in PCOS patients

Physiology-guided complete revascularization in older patients with myocardial infarction

Metals and sulfate in air pollution mixture may contribute most to asthma hospitalizations

Understanding the profound yet hidden effects of neglect on white matter structures

SEOULTECH researchers develop revolutionary 3D-printed smart materials create high-performance pressure sensors for wearables

Pusan National University scientists develop self-deploying material for next-gen robotics

Remote screening for asymptomatic atrial fibrillation

Inflammation may explain why women with no standard modifiable risk factors have heart attacks and strokes

[Press-News.org] New antibody targeting approach, tested in mice, improves distribution and safety of Alzheimer’s immunotherapies
Summary author: Walter Beckwith